Project ECHO for Human Papillomavirus Vaccines

Penn State College of Medicine, Hershey, PA
Human Papillomavirus Vaccines+1 More ConditionsProject ECHO - Other
Eligibility
18+
All Sexes

Study Summary

This trial will test the effectiveness of two HPV vaccination communication interventions (Announcement Approach Training and recall notices) delivered through the ECHO Model, compared to a control group.

Eligible Conditions
  • Human Papillomavirus Vaccines
  • Adolescent Health Services

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Similar Trials

1
(Intervention) Recommending HPV vaccine for patients 9-10 years of age
2
VLA15
2
VLA15

Study Objectives

1 Primary · 13 Secondary · Reporting Duration: Twelve months

Nine months
HPV vaccination (completion), 11-14 year olds at 9 months
HPV vaccination (≥1 dose), 11-14 year olds at 9 months
HPV vaccination (≥1 dose), 15-17 year olds at 9 months
Six months
HPV vaccination (completion), 11-14 year olds at 6 months
HPV vaccination (≥1 dose), 11-14 year olds at 6 months
HPV vaccination (≥1 dose), 15-17 year olds at 6 months
Three months
HPV vaccination (completion), 11-14 year olds at 3 months
HPV vaccination (≥1 dose), 11-14 year olds at 3 months
HPV vaccination (≥1 dose), 15-17 year olds at 3 months
Twelve months
HPV vaccination (completion), 11-14 year olds at 12 months
HPV vaccination (≥1 dose), 11-14 year olds at 12 months
HPV vaccination (≥1 dose), 11-14 year olds at 12 months by sex
HPV vaccination (≥1 dose), 15-17 year olds at 12 months
HPV vaccination (≥1 dose), 15-17 year olds at 12 months by sex
Meningococcal vaccination (≥1 dose), 11-14 year olds
Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination, 11-14 year olds

Trial Safety

Phase-Based Safety

1 of 3

Similar Trials

1
(Intervention) Recommending HPV vaccine for patients 9-10 years of age
3
VLA15
3
VLA15

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

3 Treatment Groups

Control
1 of 3
HPV ECHO+
1 of 3
HPV ECHO
1 of 3

Active Control

Experimental Treatment

36 Total Participants · 3 Treatment Groups

Primary Treatment: Project ECHO · No Placebo Group · N/A

HPV ECHO+Experimental Group · 3 Interventions: Recall notices, Project ECHO, Announcement Approach Training · Intervention Types: Other, Other, Other
HPV ECHOExperimental Group · 2 Interventions: Project ECHO, Announcement Approach Training · Intervention Types: Other, Other
ControlNoIntervention Group · 1 Intervention: Control · Intervention Types:

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: twelve months

Who is running the clinical trial?

Milton S. Hershey Medical CenterLead Sponsor
469 Previous Clinical Trials
2,785,971 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,283 Previous Clinical Trials
41,235,362 Total Patients Enrolled
William A Calo, PhD, JD, MPHPrincipal InvestigatorPenn State College of Medicine

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Frequently Asked Questions

Are there any openings for participants in this trial?

"According to information available on clinicaltrials.gov, this trial is actively seeking potential participants. The study was initially listed on May 1st 2021 and the most recent edit occurred April 29th 2022." - Anonymous Online Contributor

Unverified Answer

How many research participants have been recruited thus far for this investigation?

"Affirmative, the information available on clinicaltrials.gov verifies that this medical trial is presently recruiting patients. It was initially advertised on May 1st 2021 and modified most recently on April 29th 2022. The study requires 36 volunteers to be recruited from one site." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top